Tag: LSE:ASC

FTC to Block Amgen’s Acquisition The Federal Trade Commission (FTC) is set to block Amgen’s (NASAQ:MAGN) proposed acquisition of Horizon Therapeutics (NASDAQ:HZNP), signaling a renewed effort by antitrust enforcers to prevent mergers in the pharmaceutical industry. According to a person familiar with the matter, the FTC plans to seek an injunction in federal court to…